Skip to main content
Figure 3 | BMC Infectious Diseases

Figure 3

From: Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis

Figure 3

Impact of different tests on mortality in (A) adult extrapulmonary and (B) pediatric tuberculosis. Trajectory of extrapulmonary tuberculosis (TB) mortality in adults (A) and overall TB mortality in children (B) over 10 years without further intervention (maroon line), with introduction of Xpert for adult pulmonary TB (green line; coverage 15%, 30%, 30% among new, previously treated and failure cases), POC sputum NAAT (purple line; coverage of 50%, 80%, 100%), NAAT-EPTB (black line in A) and NAAT-Peds (black line in B; the latter two both at the same coverage as Xpert). In addition, we project the incremental impact of POC-non-sputum NAAT (orange line).

Back to article page